Robert Nordal

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Brigitta G. Baumert, Monika E. Hegi, Martin J. van den Bent et al. · The Lancet Oncology · 2016 · 485 citations · Full text

Neuro-oncology, Glioma, Radiation Therapy +10

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 407 citations

Surgical Oncology, Breast Oncology, Radiation Therapy +11

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).

Steven J. Chmura, Kathryn Winter, Wendy A. Woodward et al. · Journal of Clinical Oncology · 2022 · 188 citations

Surgical Oncology, Breast Oncology, Cancer Management +19

Hypoxia and Hypoxia-Inducible Factor-1 Target Genes in Central Nervous System Radiation Injury

Robert Nordal, András Nagy, Melania Pintilie et al. · Clinical Cancer Research · 2004 · 183 citations · Full text

Hypoxia in radiation-induced blood-spinal cord barrier breakdown.

Yuqing Li, James R. Ballinger, Robert Nordal et al. · PubMed · 2001 · 131 citations

Radiation Effect, Radiation Exposure, Radiation Biology +19